Sure.....licences and brevagen will continue to drive revenues...

Sure.....licences and brevagen will continue to drive revenues up, as will the sp (the latter is already occurring).

However, as for market cap of approx 70+ million which is also likely to increase (substantially) moving forward, don't forget about that 'little' Immunaid project.

In my opinion (and according to others in the field), a year from now, not only will Immunaid be the golden egg for GTG/GENE, it will be worth more than the total market cap of Genetic Technologies in its own right.

Watch this space !!